Thermax Limited (THERMAX)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q1 FY27 was challenging with a significant INR 91 crore loss on a government project nearing completion
- INR 300 crore shipment delay impacted Industrial Products profitability due to Gulf war-related logistics
- Bio-CNG and FEPL segments faced losses due to project delays and restructuring; Bio-CNG losses expected to end by Q3
- Order backlog strong with expected growth in Industrial Infra, Industrial Products, Chemicals, and TBWES segments
- Data centre cooling solutions pipeline growing; hydrogen project order expected next quarter
- Legacy government projects reduced to INR 300 crore, less than 5% of order book; focus on profitable private and international projects
- Management committed to improved project execution and transparency; expects profitability growth and order inflow exceeding last year
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 THERMAX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add THERMAX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Thermax Limited
Important.
The summary above is generated automatically from Thermax Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.